Last updated: 11/07/2018 18:34:54

An Observational Study to Assess Prevalence, Natural History, and Burden of Illness of Irritable Bowel Syndrome (IBS) in Clinical Practice and to Evaluate the Impact of Alosetron Treatment on Natural History and Burden of Illness in a Cohort of Females Whose Predominant Bowel Symptom is Diarrhea

GSK study ID
S3B40032
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: An Observational Study to Assess Prevalence, Natural History, and Burden of Illness of Irritable Bowel Syndrome (IBS) in Clinical Practice and to Evaluate the Impact of Alosetron Treatment on Natural History and Burden of Illness in a Cohort of Females Whose Predominant Bowel Symptom is Diarrhea
Trial description: An Observational Study to Assess Prevalence, Natural History, and Burden of Illness of Irritable Bowel Syndrome (IBS) in Clinical Practice and to Evaluate the Impact of Alosetron Treatment on Natural History and Burden of Illness in a Cohort of Females Whose Predominant Bowel Symptom is Diarrhea
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Co morbid Conditions In Patients With Irritable Bowel Syndrome: Data From A National IBS Awareness Registry ,abstract of Digestive Disease Week 2001; May 20-23, 2001; Atlanta, Georgia.
Differences in Productivity, QoL, and Resource Use in Newly Diagnosed and Established IBS Patients ,abstract of Digestive Disease Week 2001; May 20-23, 2001; Atlanta, Georgia.
Markowitz M, Jhingran P, Asgharian A, Wentz A, Gordon S, Carter E. IBS Prevalence: results form a community based patient registry based on the Rome II criteria. Program and abstracts of the American College Gastroenterology meeting; Oct 16-18 , 2000; New York, NY. Am J Gastro 95(9): 2634, 2000
Northcutt A, Mangel A, Hamm L, et al, IBS Subtypes: Co morbid Conditions In Patients With Irritable Bowel Syndrome: Data From A National IBS Awareness Registry. Program and abstracts of Digestive Disease Week 2001; May 20-23, 2001; Atlanta, Georgia. Poster #3243
Northcutt A, Mangel A, Hamm L, et al, IBS Subtypes: Differences in QoL Impairment, Productivity Loss and Resource Use. Program and abstracts of Digestive Disease Week 2001; May 20-23, 2001; Atlanta, Georgia. Poster #3243
Symptom Patterns in IBS Pateints,abstract of Digestive Disease Week 2001; May 20-23, 2001; Atlanta, Georgia.
Medical condition
Irritable Colon
Product
alosetron
Collaborators
Not applicable
Study date(s)
January 2000 to November 2000
Type
Not applicable
Phase
4

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Not applicable

Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2000-28-11

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website